PREVIEW: CELG Stock Analysis with Charles Duncan
Rate:
46,873 ratings
Views: 334
From: BioBusinessTV
Added: 18 years ago · 1:16 · 480p
You are Watching: Celgene's Revlimid, Markets and Revenues, with Charles Duncan. What are the next areas of growth for ...
Comments
No comments yet.